Disposition of 635 shares by Peters William J of Amphastar at 41.2946 subject to Rule 16b-3
AMPH Stock | USD 40.84 1.40 3.31% |
Under 55% of Amphastar's investor base is interested to short. The analysis of overall sentiment of trading Amphastar P stock suggests that many investors are impartial at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
Filed transaction by Amphastar P Director, Officer Cfo, Evp Treasurer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Amphastar's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Amphastar's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Amphastar Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amphastar can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Amphastar is number one stock in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
EBS | Emergent Biosolutions | 4.60 | ||||
NBIX | Neurocrine Biosciences | 2.74 | ||||
ALVO | Alvotech | 2.12 | ||||
HLN | Haleon Plc | 1.95 | ||||
TEVA | Teva Pharma | 0.06 | ||||
AMPH | Amphastar | 3.31 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |